Your browser doesn't support javascript.
loading
Application of Data Science to Quantify the Effect of Propofol Infusion on Postoperative Nausea and Vomiting.
Hoornstra, Edward; Velagapudi, Nishant; Bryant, John T; Roberts, Douglas; Behara, Lakshmana; Venigandla, Ravitheja; Mani, Prakash; Nair, Bala G.
Afiliación
  • Hoornstra E; is the associate chief CRNA at Mission Anesthesia, North Carolina Division of HCA HealthCare. Email: Edward.Hoornstra@HCAHealthcare.com.
  • Velagapudi N; is the Vice President of Data Science and AI at Perimatics LLC, Bellevue, Washington. Email: nishant@perimatics.com.
  • Bryant JT; was the chief of Anesthesia at Mission Anesthesia, North Carolina Division of HCA HealthCare. Email: John.Bryant1@HCAHealthcare.com.
  • Roberts D; is the associate chief CRNA at Mission Anesthesia, North Carolina Division of HCA HealthCare. Email: Edward.Hoornstra@HCAHealthcare.com.
  • Behara L; is a senior data scientist at Perimatics LLC, Bellevue, Washington. Email: lakshmanab@perimatics.com.
  • Venigandla R; is a senior data scientist at Perimatics LLC, Bellevue, Washington. Email: ravit@perimatics.com.
  • Mani P; is the senior data engineering manager at Perimatics LLC, Bellevue, Wa,shington. Email: prakashm@perimatics.com.
  • Nair BG; is the Chief Technology Officer at Perimatics LLC, Bellevue, Washington. He is also an Associate Professor of Anesthesiology at University of Washington, Seattle, Washington. Email: bala@perimatics.com.
AANA J ; 90(4): 263-270, 2022 Aug.
Article en En | MEDLINE | ID: mdl-35943751
ABSTRACT
The effectiveness of propofol infusion on postoperative nausea and vomiting (PONV) is poorly understood in relation to various patient and procedure characteristics. This retrospective cohort study aimed to quantify the effectiveness of propofol infusion when administered either via total intravenous administration (TIVA) or combined intravenous anesthesia (CIVA) with inhalational agents on PONV. The relationship between propofol infusion and PONV was characterized controlling for patient demographics, procedure characteristics, PONV risk factors, and antiemetic drugs in adult patients (age ≥18 years) undergoing general anesthesia. Learned coefficients from multivariate regression models were reported as "lift" which represents the percentage change in the base likelihood of observing PONV if a variable is present versus absent. In a total of 41,490 patients, models showed that propofol infusion has a naive effect on PONV with a lift of -41% (P < .001) when using TIVA and -17% (P < .001) when using CIVA. Adding interaction terms to the model resulted in the loss of statistical significance in these relationships (lift of -30%, P = .23, when using TIVA, and -42%, P = .36, when using CIVA). It was further found that CIVA/TIVA are ineffective in short cases (CIVA * short surgery duration lift = 49%, P < .001 and TIVA * short surgery duration lift = 56%, P < .001).
Asunto(s)
Palabras clave
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Propofol / Náusea y Vómito Posoperatorios Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans Idioma: En Revista: AANA J Año: 2022 Tipo del documento: Article
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Propofol / Náusea y Vómito Posoperatorios Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans Idioma: En Revista: AANA J Año: 2022 Tipo del documento: Article